Please ensure Javascript is enabled for purposes of website accessibility

These 4 Companies Could Alter the Future of Telehealth

By Leo Sun - Feb 6, 2014 at 11:01AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

New technologies from Google, Microsoft, iRobot, and Medtronic could dramatically alter the future of telehealth, or remote health care.

42% of U.S. hospitals are now using telehealth platforms to treat patients remotely, according to a new report published in February's Health Affairs  journal.

The report -- conducted by the Center for Connected Health, University of Michigan, and Brigham and Women's Hospital -- revealed that telehealth adoption was higher in rural areas compared to urban ones. On a state-by-state basis, Alaska topped the list with a 75% adoption rate, while Rhode Island was at the bottom with 0%.

This interesting trend represents a key point of convergence between technology and health care, in which companies like Google (GOOGL -2.49%), Microsoft (MSFT -1.39%), iRobot (IRBT -0.18%), and Medtronic (MDT -0.36%) are taking center stage.

Google Helpouts lets doctors help patients remotely
In a previous article, I discussed three ways search giant Google could revolutionize health care -- through biotech, medical devices, and electronic health records (EHRs). One additional way is through remote telehealth connections.

Some people might remember Google Answers, an online knowledge marketplace launched in 2002 but closed (except in Hong Kong) in 2006. The service allowed users to pay money to ask a Google-vetted researcher to answer questions. Accepted answers could cost between $2 to $200, with Google taking a 25% cut of the researcher's payment and an additional $0.50 per question. The client could leave a tip up to $100.

Last November, Google launched the successor to Google Answers, known as Google Helpouts. Instead of using a flat rate per question payment model, Google Helpouts lets experts charge clients per session, per minute, or both. Clients need a Google+ account, payments are made via Google Wallet, and Google takes a 20% cut of the fee.

Google Helpouts. Source: Author's screenshot.

Helpouts' video question and answer platform can be used for a wide variety of purposes, but improving telehealth is one of Google's top priorities. Google waives its 20% for all health care related questions, and it ensures that all of its video interchanges are HIPAA (Health Insurance Portability and Accountability Act) compliant.

Helpouts has attracted individual physicians and companies such as One Medical, all of whom consider it to be a useful tool in scheduling remote appointments for busy or distant patients. Cloud-connected remote monitoring devices -- such as blood pressure monitors, pacemakers, and glucose monitors -- could eventually be added for real-time physical examinations as well.

Paging Dr. Kinect
Although Microsoft's Kinect is usually recognized as a motion-control peripheral for Xbox 360 and Xbox One video games, Microsoft's joint venture with Accentureknown as Avanade, has transformed the device into an important telehealth tool as well.

Avanade accomplishes this by combining the motion-tracking abilities of the Kinect (which uses cameras to synchronize to the user's body parts), Skype video chat, and Microsoft's HealthVault cloud-based EHR program.


Physicians using the Kinect as a telehealth device can go a step further than Google Helpouts by instructing patients to perform physical movements to gauge flexibility and a range of movement, all of which can be measured by the Kinect's cameras. The Kinect can also use a pre-programmed set of instructions to conduct a preliminary exam without a doctor present, shortening the length of the remote care session. The results are then recorded over the cloud into HealthVault. The whole system can cost less than $1,000, depending on the setup of the PC. Neither Google nor Microsoft generate meaningful revenue from these telehealth projects, but they could catch on quickly, thanks to their massive footprints in the consumer tech market.

The 5-foot tall robot doctor will see you now
iRobot, the company best known for its Roomba vacuum robots, has created the RP-VITA (Remote Presence Virtual and Independent Telemedicine Assistant), a 5-foot tall robot which is equipped with a video screen, webcam, and an onboard stethoscope.

The RP-VITA can navigate hospitals and locate patients independently using a programmed map. The physician then interacts with the patient via an Apple iPad.

Source: iRobot.

The RP-VITA can be used in a wide variety of situations as long as a constant Internet connection is available. For example, the robot could be sent to remote locations lacking adequate medical facilities, or used in quarantined environments too risky for human doctors to enter. So far, robots have only been installed in seven hospitals in the U.S. and Mexico, but at a relatively low cost of $4,000 - $6,000 per month, use could spread over the next decade. Although the RP-VITA isn't a meaningful contributor to iRobot's top line yet, it could eventually represent a way to diversify away from its domestic robots (Roomba, Scooba, Mirra, Looj), which accounted for 89% of its revenue last quarter.

Medtronic's remote monitoring devices could save lives
Medtronic, the largest medical device maker in the world, is also a key name to watch in telehealth. Several of Medtronic's insulin pumps, glucose monitors, and heart devices can transfer patient data over the Internet to a secure server on its CareLink website. In its cardiac devices, Medtronic's OptiVol Fluid Status Monitoring system can detect fluid buildup in the thoracic cavity and send a report to the patient's doctor in a timely manner.

For diabetics, Medtronic's insulin pumps and CGM (continuous glucose monitoring) devices upload periodic insulin trend reports to the CareLink server. Medtronic has stated that its eventual goal is to provide a patient's entire care team with continuous real-time glucose therapy information to avoid life-threatening high or low glucose conditions.

An illustration of how CareLink works. Source: Medtronic.

To accelerate its efforts in telehealth, Medtronic acquired Cardiocom, a maker of remote monitoring devices for heart disease patients, for $200 million in August 2013.

Enhancing its cardiac and diabetes devices with better connectivity could boost sales at both business segments. Last quarter, sales of Medtronic's cardiac and diabetes devices only edged up 2.9% and 4% year over year, respectively. The two segments account for nearly two-thirds of the company's revenue.

The Foolish takeaway
When we combine these pieces of telehealth technology offered by Google, Microsoft, iRobot, Medtronic, and other companies, the future becomes clear -- more patients in rural areas will have immediate access to quality health care, and visits to the doctor's office could only be a mouse click (or touch of a finger) away.

Leo Sun owns shares of Apple. The Motley Fool recommends Accenture, Apple, Google, and iRobot. The Motley Fool owns shares of Apple, Google, Medtronic, and Microsoft. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Alphabet Inc. Stock Quote
Alphabet Inc.
$117.18 (-2.49%) $-2.99
Microsoft Corporation Stock Quote
Microsoft Corporation
$286.13 (-1.39%) $-4.04
Medtronic plc Stock Quote
Medtronic plc
$94.89 (-0.36%) $0.34
iRobot Stock Quote
$59.41 (-0.18%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.